| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic Mineral Metabolism |





* INSERM Unit 507 and
Laboratory of Biochemistry A, Necker Hospital, Paris, and
Centre de Morphologie Mathématique, Ecole des Mines, Fontainebleau, France; and
Divisions of Clinical Pharmacology and Nephrology, University of Picardie and Amiens University Hospital, Amiens; and || Department of Biological Sciences, Lehman College, Bronx, New York
Address correspondence to: Dr. Ziad A. Massy, INSERM Unit 507, Necker Hospital, 161, Rue de Sèvres 75015 Paris, France. Phone: + 33-1-44-49-52-34; Fax: + 33-1-45-66-51-33; E-mail: massy{at}u-picardie.fr
Chronic renal failure (CRF) favors the development of atherosclerosis and excessive calcification of atheromatous lesions. CRF was induced in apolipoprotein E knockout (apoE/) mice to study (1) a possible acceleration of aortic atherosclerosis, (2) the degree and type of vascular calcification, and (3) factors involved in the calcification process. For creating CRF, 8-wk-old apolipoprotein E gene knockout (apoE/) mice underwent partial kidney ablation. Control animals underwent sham operation. Aortic atherosclerotic plaques and calcification were evaluated using quantitative morphologic image processing. At 6 wk after nephrectomy, CRF mice had significantly higher serum urea, cholesterol, and triglyceride concentrations than non-CRF controls. The serum levels of advanced oxidation protein products were elevated in the uremic group and were correlated with serum urea levels. Atherosclerotic lesions in thoracic aorta were significantly larger in uremic apoE/ mice than in nonuremic controls. The relative proportion of calcified area to total surface area of both atherosclerotic lesions and lesion-free vascular tissue was increased in aortic root of uremic apoE/ mice when compared with controls. The calcium deposits were made of hydroxyapatite and calcite crystals. In addition, plaques from uremic animals showed a significant increase in collagen content, whereas the degree of macrophage infiltration was comparable in both groups. There was no difference in mean arterial BP. These findings demonstrate that CRF aggravates atherosclerosis in apoE/ mice. Moreover, CRF enhances arterial calcification at both atheromatous intimal sites and atheroma-free medial sites. We anticipate that this experimental model will be useful to test treatment strategies aimed at decreasing the accelerated atherosclerosis and arterial calcification in uremia
This article has been cited by other articles:
![]() |
K. Amann Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1599 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska Vitamin D Receptor Activators Can Protect against Vascular Calcification J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1509 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Phan, O. Ivanovski, I. G. Nikolov, N. Joki, J. Maizel, L. Louvet, M. Chasseraud, T. Nguyen-Khoa, B. Lacour, T. B. Drueke, et al. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure Nephrol. Dial. Transplant., January 1, 2008; 23(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bang, S. Bro, E. D. Bartels, T. X. Pedersen, and L. B. Nielsen Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1325 - F1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Westenfeld, C. Schafer, R. Smeets, V. M. Brandenburg, J. Floege, M. Ketteler, and W. Jahnen-Dechent Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1537 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bro, C. J. Binder, J. L. Witztum, K. Olgaard, and L. B. Nielsen Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1080 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krasniak, M. Drozdz, M. Pasowicz, G. Chmiel, M. Michalek, D. Szumilak, P. Podolec, P. Klimeczek, M. Konieczynska, E. Wicher-Muniak, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients Nephrol. Dial. Transplant., February 1, 2007; 22(2): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nikolov, N. Joki, T. Drueke, and Z. Massy Beyond phosphate--role of uraemic toxins in cardiovascular calcification Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3354 - 3357. [Full Text] [PDF] |
||||
![]() |
E. Ritz and C. Wanner Lipid Changes and Statins in Chronic Renal Insufficiency J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S226 - S230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Amann, C. Wanner, and E. Ritz Cross-Talk between the Kidney and the Cardiovascular System J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2112 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bro, R. Borup, C. B. Andersen, F. Moeller, K. Olgaard, and L. B. Nielsen Uremia-Specific Effects in the Arterial Media During Development of Uremic Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Karra, S. Vemullapalli, C. Dong, E.E. Herderick, X. Song, K. Slosek, J.R. Nevins, M. West, P.J. Goldschmidt-Clermont, D. Seo, et al. Stem Cells of Aging Donors--Insufficient Capacity to Repair Causes Progression of Atherosclerosis in the Recipient: Molecular Evidence for Arterial Repair in Atherosclerosis. Proc Natl Acad Sci U S A 102: 16789-16794, 2005 J. Am. Soc. Nephrol., February 1, 2006; 17(2): 317 - 322. [Full Text] [PDF] |
||||
![]() |
E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction J. Am. Soc. Nephrol., February 1, 2006; 17(2): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hyafil, J.-P. Laissy, M. Mazighi, D. Tchetche, L. Louedec, H. Adle-Biassette, S. Chillon, D. Henin, M.-P. Jacob, D. Letourneur, et al. Ferumoxtran-10-Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 176 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. Zhang, D.E. Kohan, R.D. Nelson, F.J. Gonzales, T. Yang, C. Schmidt-Lucke, L. Rossig, S. Fichtlscherer, M. Vasa, et al. Edema and Congestive Heart Failure from Thiazolidone Insulin Sensitizers--Excess Sodium Reabsoption in the Collecting Duct: Collecting Duct-Specific Deletion of Peroxisome Proliferator-Activated Receptor {gamma} Blocks Thiazolidinedione-Induced Fluid Retention. Proc Nat Acad Sci U S A 102: 9406-9411, 2005 J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3139 - 3142. [Full Text] [PDF] |
||||
![]() |
O. Phan, O. Ivanovski, T. Nguyen-Khoa, N. Mothu, J. Angulo, R. Westenfeld, M. Ketteler, N. Meert, J. Maizel, I. G. Nikolov, et al. Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice Circulation, November 1, 2005; 112(18): 2875 - 2882. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673